Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
The Future of Heart Failure With Dr Yancy
Author(s): Clyde W Yancy Added: 4 months ago
AHA Scientific Sessions 2025 - Dr Clyde Yancy (Northwestern University, US) joins us to explore the future trajectory of heart failure management, examining how prevention strategies, precision medicine approaches, and the evolving responsibilities of cardiologists are reshaping patient outcomes.Interview Questions:Looking at the current state of heart failure management, what do you see as the… View more

Guidelines & Statements

Heart Failure
Precision in Practice: Navigating Amyloidosis Diagnosis and Referral
Author(s): Margot K Davis , , , et al Added: 11 months ago
In this symposium, filmed at HFA 2025 (Belgrade, RS), moderator Dr Margot Davis (Vancouver, CA) is joined by Prof Fabian Knebel (Berlin, DE), Dr AleksandarAleksandrov (Berlin, DE) and Prof Olivier Lairez (Toulouse, FR) to unpack a recent, real-life patient referral. The faculty explore the challenges faced during the referral process and then evaluate the practical steps for making a confident… View more

Heart Failure
Job title: Co-founder and Medical Director of CORRIB Research Center for Advanced Cardiovascular Imaging and Core Laboratory
Professor Osama Soliman a clinical cardiologist with more than 2 decades of experience in cardiovascular imaging, clinical trials and innovation in medicine has pioneered several non-invasive imaging techniques and methods. He holds the position of Professor with a personal chair in cardiovascular research at the National University of Ireland Galway. He is the co-founder and Medical Director… View more
Brian Ference
Dr Brian A Ference is currently Director of Research (Professor) in Translational Therapeutics, and Executive Director of the Centre for Naturally Randomized Trials at the University of Cambridge, UK; and Visiting Professor in Cardiovascular Medicine at the University of Milan, Italy. Prior to his current post in Cambridge, his previous positions included Chief of Cardiology and Director of the… View more
Jiguang Wang
Job title: Director
Dr Wang is Director of the Shanghai Institute of Hypertension, Director of the Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. At present, he is coordinating several multicentre randomised clinical trials and population- and patient-cohort studies in China. He has published 587 full-length articles on hypertension in the international… View more
MISSIONSOur primary mission is to develop translational approaches to Unmet Healthcare Needs for which solutions are unknown and/or underutilized.The TMA uses Evidence Building, Education, and Advocacy Programs to address these needs.TMA MandatesSupport translational science through financing opportunities and medical activitiesProvide Continuing Medical Education (CME) and Continuous… View more
Jong-Il Choi, MD, PhD, MHS
Research Area(s) / Expertise:

Electrophysiology & Arrhythmia

 Job title: Professor of Medicine
Jong-Il Choi, MD, PhD, MHS is the Tenured Full Professor of Medicine at Korea University. He received MD and PhD degree from Korea University. He trained residency of internal medicine, fellowship of cardiology & cardiac electrophysiology at Korea University Hospital. He had a 2 year-basic research period (2013-2015) as a visiting scholar at Duke University (Dr. Geoffrey Pitt Lab, Ion Channel… View more
Antoni Bayés-Genís
Research Area(s) / Expertise: Job title: Head of the Cardiology Department
Antoni Bayés-Genís is Head of the Heart Institute at the University Hospital Germans Trias i Pujol in Barcelona, and Professor of Cardiology at the Universitat Autònoma de Barcelona in Barcelona, Spain.Prof Bayés-Genís is an expert on biomarker, including natriuretic peptides ST2 and neprilysin, having lectured on the subject at numerous international meetings and generated research data that… View more
Added: 3 months ago Source:  Radcliffe Cardiology
A novel cardiac myosin agonist, danicamtiv, has shown favourable safety and efficacy signals in patients with dilated cardiomyopathy (DCM), particularly in those with specific genetic variants, according to results from a phase 2a open-label trial.¹ Precision therapies for DCM are currently lacking, despite its diverse clinical manifestations often linked to underlying genetic causes.²Danicamtiv… View more

Imaging & Diagnostics

Inherited and Congenital Cardiac Conditions